Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USDA Retracts Statement Barring OTCs, Supplements From Organics Program

This article was originally published in The Tan Sheet

Executive Summary

The USDA Agricultural Marketing Service will retract a recent statement clarifying that dietary supplements and OTCs cannot be certified under the National Organic Program, according to the agency

You may also be interested in...



Standards Coming This Year For Organic Personal, Health Care Products

A task force of industry representatives and consumer advocates by mid-2007 will release the first draft of standards for organic personal care products, including health care items such as toothpaste as well as cosmetics and personal hygiene products, insiders say

Standards Coming This Year For Organic Personal, Health Care Products

A task force of industry representatives and consumer advocates by mid-2007 will release the first draft of standards for organic personal care products, including health care items such as toothpaste as well as cosmetics and personal hygiene products, insiders say

Standards Coming This Year For Organic Personal, Health Care Products

A task force of industry representatives and consumer advocates by mid-2007 will release the first draft of standards for organic personal care products, including health care items such as toothpaste as well as cosmetics and personal hygiene products, insiders say

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel